Leukemia Treatment Market: By Leukemia Type (Chronic Leukemia, Chronic Lymphatic Leukemia, Chronic Myeloid Leukemia, Acute Leukemia, Acute Lymphatic Leukemia, Acute Myeloid Leukemia, and Others), by Therapy (Chemotherapy, Biological Therapy, Radiation Therapy, Targeted Therapy, and Other) and By Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Leukemia Treatment Market size was valued at USD 14.09 billion in 2022 and is expected to reach USD 26.08 billion by 2029, at a CAGR of 7.9% during the forecast period 2023-2029. Abnormal white blood cells beginning in the bone marrow of blood forming tissues results in a group of cancers collectively called as Leukemia. Leukemia is a cancer of blood-forming tissues in the body. Treatment of leukemia is done by blood transfusion, immunotherapy, bone marrow transplantation, radiation therapy and chemotherapy, biological therapy, targeted therapy, stem cell transplant. The drugs that are available in the market include the following: Gleevec, Bosulif, Sprycel, Iclusig etc. Bosutinib, omapro, quizartinib, graspa, and marquibo among others are the pipeline drugs under clinical trials yet to be launched with a promising potential to treat leukemia with minimal side effects. Based on the epidemiological factors, leukemia is forecasted to be more predominant in whites when compared to people of other racial or ethnic groups due to high incidence and mortality rates. Furthermore, exposure to radiation with genetic and environmental factors play a prominent role in increasing the prevalence of leukemia. Generally, men are more likely to develop leukemia than women. The risk of leukemia is majorly associated with age. The occurrence of leukemia is high in men and women aging over 66 years. Adults, both men and women normally aged in between 75 to 84 are more prevalent to the different types of leukemia such as chronic lymphocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. The prevalent rate of acute lymphocytic leukemia is high among 1 to 4 year old children and it is nearly eight times more than the young adults aging 20 and 24.

Leukemia Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.9%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific
Leukemia Treatment Market Dynamics

The global leukemia treatment market is majorly driven by the increasing prevalance of the disease across the globe. Healthcare awareness among the people and rising research & development activities resulting in recent advancements of technology and therapeutics. The growth rate of global leukemia treatment market also depends on the pipeline drugs which are major growth drivers for global leukemia therapeutics market in near future. The factors restraining the growth of the market include the high price of combination therapies and lack of access in developing and underdeveloped countries.

Key Features of the Reports

  • The leukemia treatment market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market

Leukemia Treatment Market Segmentation

By Type
  • Chronic leukemia
    • o Chronic Lymphatic Leukemia
    • o Chronic Myeloid Leukemia
  • Acute Leukemia
    • o Acute Lymphatic Leukemia
    • o Acute Myeloid Leukemia
  • Others
By Therapy type
  • Chemotherapy
  • Biological Therapy
  • Radiation therapy
  • Targeted therapy
  • Other
By Geography
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Afica

Frequently Asked Questions

The Leukemia Treatment Market size was valued at USD 14.09 billion in 2022

The Leukemia Treatment Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Asia Pacific is the fastest-growing for Leukemia Treatment Market

 

  1. Executive Summary
  2. Global Leukemia Treatment Market Introduction
    • Global Leukemia Treatment Market Taxonomy
    • Global Leukemia Treatment Market Definitions
      • Leukemia Type
      • Treatment Type
  1. Global Leukemia Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Leukemia Treatment Market Dynamic Factors - Impact Analysis
    • Global Leukemia Treatment Market Competition Landscape
    • Epidemiology
  2. Global Leukemia Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Leukemia Treatment Market, By Leukemia Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Chronic Leukemia
      • Chronic Lymphatic Leukemia
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Chronic Myeloid Leukemia
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Acute Leukemia
        • Acute Lymphatic Leukemia
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Acute Myeloid Leukemia
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Others
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
  1. Global Leukemia Treatment Market Forecast, By Treatment Type, 2018 - 2022 and Forecast, 2023 - 2029
    • Chemotherapy
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Biological Therapy
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Radiation Therapy
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Targeted Therapy
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Leukemia Treatment Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Leukemia Treatment Market - Opportunity Analysis Index, By Leukemia Type, By Treatment Type, and Region, 2023 - 2029
  2. North America Leukemia Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Leukemia Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Chronic Leukemia
        • Chronic Lymphatic Leukemia
        • Chronic Myeloid Leukemia
      • Acute Leukemia
        • Acute Lymphatic Leukemia
        • Acute Myeloid Leukemia
      • Others
    • Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Chemotherapy
      • Biological Therapy
      • Radiation therapy
      • Targeted therapy
      • Others
    • Country Analysis 2016 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US.
      • Canada
    • North America Leukemia Treatment Market - Opportunity Analysis Index, By Leukemia Type, By Treatment Type, and Country, 2023 - 2029
    • North America Leukemia Treatment Market Dynamics Trends
  3. Europe Leukemia Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Leukemia Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Chronic Leukemia
        • Chronic Lymphatic Leukemia
        • Chronic Myeloid Leukemia
      • Acute Leukemia
        • Acute Lymphatic Leukemia
        • Acute Myeloid Leukemia
      • Others
    • Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Chemotherapy
      • Biological Therapy
      • Radiation therapy
      • Targeted therapy
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Leukemia Treatment Market - Opportunity Analysis Index, By Leukemia Type, By Treatment Type, and Country,2023 - 2029
    • Europe Leukemia Treatment Market Dynamics Trends
  4. Asia-Pacific Leukemia Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Leukemia Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Chronic Leukemia
        • Chronic Lymphatic Leukemia
        • Chronic Myeloid Leukemia
      • Acute Leukemia
        • Acute Lymphatic Leukemia
        • Acute Myeloid Leukemia
      • Others
    • Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Chemotherapy
      • Biological Therapy
      • Radiation therapy
      • Targeted therapy
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Leukemia Treatment Market - Opportunity Analysis Index, By Leukemia Type, By Treatment Type, and Country,2023 - 2029
    • Asia-Pacific Leukemia Treatment Market Dynamics Trends
  5. Latin America Leukemia Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Leukemia Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Chronic Leukemia
        • Chronic Lymphatic Leukemia
        • Chronic Myeloid Leukemia
      • Acute Leukemia
        • Acute Lymphatic Leukemia
        • Acute Myeloid Leukemia
      • Others
    • Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Chemotherapy
      • Biological Therapy
      • Radiation therapy
      • Targeted therapy
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Leukemia Treatment Market - Opportunity Analysis Index, By Leukemia Type, By Treatment Type, and Country, 2023 - 2029
    • Latin America Leukemia Treatment Market Dynamics Trends
  6. Middle East and Africa Leukemia Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Leukemia Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Chronic Leukemia
        • Chronic Lymphatic Leukemia
        • Chronic Myeloid Leukemia
      • Acute Leukemia
        • Acute Lymphatic Leukemia
        • Acute Myeloid Leukemia
      • Others
    • Treatment Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Chemotherapy
      • Biological Therapy
      • Radiation therapy
      • Targeted therapy
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Leukemia Treatment Market - Opportunity Analysis Index, By Leukemia Type, By Treatment Type, and Country, 2023 - 2029
    • MEA Leukemia Treatment Market Dynamics Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Leukemia Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Hoffmann-La Roche Ltd. (Switzerland)
      • Amgen, Inc. (U.S.)
      • Bristol-Myers Squibb (U.S.)
      • Novartis International AG. (Switzerland)
      • Pfizer, Inc. (U.S.)
      • Teva Pharmaceuticals Industries Ltd. (Israel)
      • GlaxoSmithKline plc. (U.K.)
      • Genzyme Corporation (U.S.)
      • AbbVie Inc. (U.S.)
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

  • F. Hoffmann-La Roche Ltd.
  • Amgen
  • Bristol-Myers Squibb
  • Novartis International AG.
  • Pfizer
  • Teva Pharmaceuticals
  • GlaxoSmithKline plc.
  • Genzyme Corporation
  • AbbVie Inc.
  • ARIAD Pharmaceuticals, Inc.

Adjacent Markets